BLOG
Comparison of Urinary Anticholinergics
Anticholinergic medications are well known for their often dose-limiting adverse effects, so do any of the medications typically used in the treatment of lower urinary tract symptoms (LUTS)...
When Should We Use Icosapent Ethyl?
As one of the few significant new treatment options approved for reducing the risk of cardiovascular events since statins were approved about 30 years ago, when should icosapent ethyl (Vascepa)...
August 2021 Update: Treatment of COVID-19 in the Hospital
Treatment for patients hospitalized with COVID-19 is continuously evolving. Some medications have proven beneficial over the past year, while others have fallen out of favor. Here we review the most...
Community-Acquired Pneumonia Treatment
Community-acquired pneumonia (CAP) is defined as pneumonia acquired outside of hospitals, (less than 48 hours from hospital admission). Patients will typically present with symptoms including fever,...
PPI Use In Lower GI Bleeds
Proton Pump Inhibitors (PPIs) are a well-known staple in the management of upper GI bleeds (UGIB). Recently, there was a question regarding the efficacy and appropriateness of PPI use in lower GI...
Drugs That Cause Hypercalcemia
Excess calcium levels can be life-threatening if they become severely elevated (>14 mg/dL), causing symptoms such as polyuria and polydipsia due to nephrogenic diabetes insipidus,...
Tapering Clonidine – Case Study
In this article, I wanted to share information on tapering clonidine. This drug can cause serious rebound hypertension when abruptly discontinued and patients may not understand or realize that this...
Comparison of DPP4 Inhibitors
While Dipeptidyl Peptidase-4 (DPP4) inhibitors aren't used incredibly often, we wanted to provide a comparison of DPP4 inhibitors. DPP4 inhibitors are used in the treatment of diabetes and function...
Comparison of PDE-5 Inhibitors
Phosphodiesterase-5 inhibitors, or PDE-5 inhibitors, are often the first-line therapy for erectile dysfunction. PDE-5 inhibitors do not produce an erection in the absence of stimulation –...
Finerenone in Chronic Kidney Disease
Last week, the FDA approved finerenone (Kerendia) to treat patients with chronic kidney disease (CKD) associated with type 2 diabetes. Finerenone is a nonsteroidal mineralocorticoid receptor...
Study Materials For Pharmacists
